HLF

Herbalife Nutrition Ltd. [HLF] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

HLF Stock Summary

Top 10 Correlated Stocks

HLF


In the News

03:52 29 Mar 2024 HLF

Why Herbalife Stock Popped Today

Herbalife replaced its CFO and announced improved guidance for 2024 today. Management cited "more stability in the business" for the positive outlook adjustment.

03:01 29 Mar 2024 HLF

Real World vs. Theoretical Investing: Part 2

Investing in the real-world and investing in theory are worlds apart. Stock Strategist Andrew Rocco provides the details you need to know to succeed and profit in the real-world.

09:41 29 Mar 2024 HLF

Shorting: Is the Risk Worth the Reward? (Insights from Market Gurus & the Pitfalls you Need to Avoid)

On shorter time frames, markets fluctuate, and there is a time to be short. However, investors should focus on long opportunities more often than not as risks are much lower and the risk-to-reward is much more favorable, all else equal.

07:00 29 Mar 2024 HLF

Kamala Harris disregarded staff recommendation to investigate Herbalife — while husband Doug Emhoff's firm repped the company

An internal memo shows Harris was urged to investigate Herbalife by her California AG staff while her husband worked for the law firm representing it.

08:45 29 Mar 2024 HLF

Herbalife (HLF) stock: Technicals point to a 62% dive

Herbalife (NYSE: HLF) stock price has imploded in a strong vindication for Bill Ackman, the billionaire who lost a billion dollars shorting it a few years ago. The stock plunged by more than 31% on Thursday as Ackman celebrated the downfall.

06:21 29 Mar 2024 HLF

Why Herbalife Stock Plummeted Today

Herbalife delivered far lower-than-expected earnings in the fourth quarter amid its ongoing "transformation program." The supplement company also told investors to expect flat revenue in the coming year.

02:03 29 Mar 2024 HLF

Herbalife's stock plunges 30%, and Bill Ackman revives his ‘pyramid' scheme attack

Shares of Herbalife Ltd. fell more than 30% on Thursday, leading activist investor Bill Ackman to revive his feud with the nutritional-supplements company.

10:01 29 Mar 2024 HLF

Herbalife Ltd. (HLF) Q4 2023 Earnings Call Transcript

Herbalife Ltd. (HLF) Q4 2023 Earnings Call Transcript

02:01 29 Mar 2024 HLF

Bill Ackman's Pershing Square re-enters ranks of world's 20 top performing hedge funds

Bill Ackman's Pershing Square Capital Management has re-entered the ranks of the world's 20 best performing hedge funds following a bumper year for the New York money manager after it previously dropped off the list in 2015.

08:13 29 Mar 2024 HLF

3 Stocks to Sell in January Before They Crash and Burn

U.S. equities are not off to a great start in 2024. The Nasdaq is down two-quarters of a percentage point, while the S&P 500 is largely flat.

HLF Financial details

Company Rating
Neutral
Market Cap
899.31M
Income
142.2M
Revenue
5.06B
Book val./share
-10.68
Cash/share
5.4
Dividend
-
Dividend %
-
Employees
9.2K
Optionable
Yes
Shortable
Yes
Earnings
30 Apr 2024
P/E
7.01
Forward P/E
3.93
PEG
-1.25
P/S
0.26
P/B
-1.18
P/C
1.86
P/FCF
7.57
Quick Ratio
0.49
Current Ratio
1.16
Debt / Equity
-2.61
LT Debt / Equity
-2.28
-
-
EPS (TTM)
1.43
EPS next Y
2.56
EPS next Q
0.42
EPS this Y
-55.83%
EPS next Y
78.67%
EPS next 5Y
78.67%
EPS last 5Y
-8.62%
Revenue last 5Y
0.75%
Revenue Q/Q
-5.17%
EPS Q/Q
-76.74%
-
-
-
-
SMA20
-
SMA50
-30.77%
SMA100
-35.71%
Inst Own
85.19%
Inst Trans
0.78%
ROA
7%
ROE
-16%
ROC
0.25%
Gross Margin
77%
Oper. Margin
8%
Profit Margin
4%
Payout
-
Shs Outstand
99.26M
Shs Float
95.43M
-
-
-
-
Target Price
18.5
52W Range
6.68-19.48
52W High
-47.03%
52W Low
+67.75%
RSI
53
Rel Volume
0.59
Avg Volume
1.97M
Volume
1.15M
Perf Week
13.09%
Perf Month
25.34%
Perf Quarter
-24.38%
Perf Half Y
-29.91%
-
-
-
-
Beta
1.213
-
-
Volatility
0.31%, 0.44%
Prev Close
6.28%
Price
10.065
Change
7.07%

HLF Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
35.542.1454.852.8451.14
Net income per share
2.262.834.223.261.44
Operating cash flow per share
3.334.784.353.583.61
Free cash flow per share
2.563.932.921.992.25
Cash per share
6.117.955.685.165.42
Book value per share
-2.84-6.51-13.14-12.85-10.71
Tangible book value per share
-5.76-9.66-17.04-17-14.85
Share holders equity per share
-2.84-6.51-13.14-12.85-10.71
Interest debt per share
15.3220.9829.3930.6429.65
Market cap
6.55B6.32B4.33B1.47B1.51B
Enterprise value
7.68B7.91B6.7B3.84B3.71B
P/E ratio
21.0616.969.694.5610.62
Price to sales ratio
1.341.140.750.280.3
POCF ratio
14.3210.059.424.164.23
PFCF ratio
18.6412.2314.037.476.79
P/B Ratio
-16.79-7.38-3.11-1.16-1.42
PTB ratio
-16.79-7.38-3.11-1.16-1.42
EV to sales
1.581.431.150.740.73
Enterprise value over EBITDA
11.2710.678.25.717.68
EV to operating cash flow
16.7912.5814.5510.910.36
EV to free cash flow
21.8615.3121.6819.5916.65
Earnings yield
0.050.060.10.220.09
Free cash flow yield
0.050.080.070.130.15
Debt to equity
-5.06-3.08-2.13-2.28-2.61
Debt to assets
0.740.861.051.060.99
Net debt to EBITDA
1.662.152.893.534.55
Current ratio
1.541.581.331.391.1
Interest coverage
4.295.164.944.092.15
Income quality
1.471.691.031.12.51
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.390.370.340.340.36
Research and developement to revenue
00000
Intangibles to total assets
0.150.130.150.150.15
Capex to operating cash flow
-0.23-0.18-0.33-0.44-0.38
Capex to revenue
-0.02-0.02-0.03-0.03-0.03
Capex to depreciation
-1.09-1.12-1.41-1.36-1.19
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
12.0220.3735.3330.7118.6
ROIC
0.220.230.330.230.13
Return on tangible assets
0.140.140.190.140.06
Graham Net
-14.2-19.57-30.89-31.94-30.5
Working capital
523.8M648.5M351.4M379.5M121.7M
Tangible asset value
-791.6M-1.27B-1.8B-1.67B-1.47B
Net current asset value
-1.58B-2.16B-2.78B-2.64B-2.47B
Invested capital
-5.06-3.08-2.13-2.28-2.61
Average receivables
75.1M81.5M75.1M68.75M75.9M
Average payables
81.35M85.15M90.35M90.9M86.9M
Average inventory
409M468.8M538.55M578.2M542.95M
Days sales outstanding
5.965.494.214.955.85
Days payables outstanding
31.0928.1427.127.9325.74
Days of inventory on hand
166.19159.06169.56180.6154.83
Receivables turnover
61.1966.5386.7473.7262.34
Payables turnover
11.7412.9713.4713.0714.18
Inventory turnover
2.22.292.152.022.36
ROE
-0.8-0.44-0.32-0.25-0.13
Capex per share
-0.77-0.85-1.43-1.59-1.36

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
12.0412.7113.2612.9212.24
Net income per share
0.550.30.60.430.1
Operating cash flow per share
0.550.471.370.80.97
Free cash flow per share
0.110.160.980.490.61
Cash per share
5.184.615.3155.4
Book value per share
-12.9-12.41-11.61-11.12-10.68
Tangible book value per share
-17.07-16.57-15.74-15.23-14.8
Share holders equity per share
-12.9-12.41-11.61-11.12-10.68
Interest debt per share
29.7828.9829.1128.2528.31
Market cap
1.46B1.59B1.31B1.39B1.52B
Enterprise value
3.84B3.95B3.63B3.66B3.71B
P/E ratio
6.7113.535.488.1137.14
Price to sales ratio
1.241.2711.081.25
POCF ratio
27.2334.339.6817.4315.77
PFCF ratio
135.1699.7413.4828.6124.92
P/B Ratio
-1.15-1.3-1.14-1.26-1.43
PTB ratio
-1.15-1.3-1.14-1.26-1.43
EV to sales
3.253.152.762.853.05
Enterprise value over EBITDA
37.7240.2423.3834.2742.54
EV to operating cash flow
71.5785.4426.7645.9338.6
EV to free cash flow
355.2248.2537.375.3961.01
Earnings yield
0.040.020.050.030.01
Free cash flow yield
0.010.010.070.030.04
Debt to equity
-2.28-2.3-2.47-2.51-2.61
Debt to assets
1.061.051.031.010.99
Net debt to EBITDA
23.3724.0714.9321.2625.16
Current ratio
1.391.081.111.161.1
Interest coverage
2.381.7932.771.35
Income quality
0.991.582.261.869.42
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.330000.35
Research and developement to revenue
00000
Intangibles to total assets
0.150.150.150.150.15
Capex to operating cash flow
-0.8-0.66-0.28-0.39-0.37
Capex to revenue
-0.04-0.02-0.03-0.02-0.03
Capex to depreciation
-1.52-1.1-1.32-1.1-1.25
Stock based compensation to revenue
0.010.010.010.010.01
Graham number
12.699.1212.5610.394.97
ROIC
0.040.040.050.040.02
Return on tangible assets
0.020.010.030.020
Graham Net
-32.07-31.67-30.95-30.49-30.41
Working capital
379.5M95M130.6M180.7M121.7M
Tangible asset value
-1.67B-1.63B-1.56B-1.51B-1.47B
Net current asset value
-2.64B-2.59B-2.55B-2.48B-2.47B
Invested capital
-2.28-2.3-2.47-2.51-2.61
Average receivables
77.8M77.85M85.7M82.9M80.35M
Average payables
87.15M78.85M78.25M83.25M80.95M
Average inventory
558.85M562.9M535.1M510.95M501M
Days sales outstanding
5.386.125.915.586.01
Days payables outstanding
30.4320.4726.4423.1226.29
Days of inventory on hand
196.77164.3156.69147.47158.09
Receivables turnover
16.7314.7115.2316.1214.96
Payables turnover
2.964.43.43.893.42
Inventory turnover
0.460.550.570.610.57
ROE
-0.04-0.02-0.05-0.04-0.01
Capex per share
-0.44-0.31-0.39-0.31-0.36

HLF Frequently Asked Questions

What is Herbalife Nutrition Ltd. stock symbol ?

Herbalife Nutrition Ltd. is a US stock , located in Los angeles of Ca and trading under the symbol HLF

Is Herbalife Nutrition Ltd. buy or a sell ?

3 stock analysts have 3 predictions with a medium analyst target price of $18.5. The lowest prediction is $9.5 and the highest is $36

What is HLF stock prediction ?

With a median analyst target price of $9.75, 2 stock analysts have made 2 forecasts in last 90 days. $9.5 is the lowest and $10 is the greatest projection.

What is Herbalife Nutrition Ltd. stock quote today ?

Herbalife Nutrition Ltd. stock price is $10.065 today.

Is Herbalife Nutrition Ltd. stock public?

Yes, Herbalife Nutrition Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap